Navigation Links
BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
Date:8/19/2010

BOCA RATON, Fla., Aug. 19 /PRNewswire/ -- The NEWTON™ Intervertebral Body Spacer System is comprised of a complete line of lumbar spinal spacers that allow anterior, posterior or lateral insertion angles to reach the intervertebral disc space.  Each implant is designed with a large central window for optimum graft placement. Initial size offerings range from 7 to 15mm high and 7 to 45mm wide in both parallel and lordotic configurations.  Through the use of a minimal-exposure patent-pending tube system, the NEWTON™ devices are implanted into the intervertebral space to provide stabilization and facilitate fusion.  Lawrence Binder, President of Binder Biomedical, Inc. (BBI) stated, "Given the implant size ranges and instruments offered, the NEWTON™ system gives surgeons the option of a less invasive approach to treat patients, where traditional instrumentation may require a longer, more traumatic surgery."

The NEWTON™ System is manufactured using the PEEK-OPTIMA® polymer from Invibio Biomaterial Solutions.  BBI has entered a supply assurance agreement with Invibio, the leader in orthopedic biomaterials, to provide its proprietary PEEK-OPTIMA® polymer for use in the NEWTON™ devices.  All devices are manufactured in FDA registered facilities located in the USA.

By incorporating a unique approach to rapid product development, BBI combines clinical feedback and industry experience to offer continuous streamlined product improvements to the spine market.  This Alpha launch of the NEWTON™ system will be followed with a full launch expected by the fourth quarter 2010. For more information on Binder Biomedical, Inc. and the NEWTON™ system please contact: sales@bindermed.com.

Binder Biomedical, Inc. is a privately held medical device company located in Boca Raton, Florida. Founded on the basis of combining quality engineering with surgeon innovation, the company provides surgeons with the highest quality medical devices for the treatment of complex orthopedic and neurological spinal disorders. Their development efforts are concentrated on products which incorporate advanced minimal exposure techniques, with the goal of providing better overall patient care. For more information about Binder Biomedical, Inc. please visit their website at:  www.bindermed.com.


'/>"/>
SOURCE Binder Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
2. Competitive Technologies Selects RF
3. Binder as Public Relations Agency of Record
4. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 Tie-up with ... initiative to save newborns   Fortis ... & newborns in collaboration with Breast Milk Foundation (BMF), a ... Pasteurized Human Milk Bank, ,Amaara, in Delhi-NCR today. This non-profit ... source for infants and should be available to babies deprived ...
(Date:4/27/2016)... YORK , April 27, 2016 ... OASM ), a developer of a new generation ... announced positive overall survival results for Paclical/Apealea in ... of 789 patients with epithelial ovarian cancer. These ... groups: Paclical/Apealea in combination with carboplatin versus Taxol ...
(Date:4/26/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) is pleased ... Pharm D., to Vice President of Education and Quality. ... will continue to lead and oversee Diplomat University, an ... and training to Diplomat employees and external professionals on ... also houses the quality assurance department, which focuses on ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... In an article ... shares her enthusiasm for Botox and lip injections, which she underwent in order to ... Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is ...
(Date:4/29/2016)... ... , ... Our bodies are bombarded daily by environmental and lifestyle factors that ... is to adopt a more healthful diet, but too many people think that food ... Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating Plan, disagrees ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... ... ... Spine Team Texas, a comprehensive spine physician group specializing in the treatment ... been invited to be a featured speaker at the Texas Society of the American ... 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation specialist, will ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... Canadian Celiac Association (CCA), is pleased to announce the launch of the ... nutritional articles, recipes, and more. The purpose of the GFCP Scoop ...
Breaking Medicine News(10 mins):